**Question:** The volatility of an anesthetic agent is directly proportional to lowering the flow in the portal vein. Portal flow is maximally reduced by –

A. Lowering arterial PCO2
B. Increasing arterial CO2
C. Increasing the central venous pressure
D. Decreasing the central venous pressure

**Correct Answer:** D. Decreasing the central venous pressure

**Core Concept:**

The volatility of anesthetic agents relies on their ability to diffuse into the bloodstream and dissolve in the blood plasma. This process is influenced by factors affecting the blood's partial pressure and composition, including arterial PCO2 (carbon dioxide partial pressure), arterial CO2 (carbon dioxide concentration), central venous pressure (CVP), and central venous oxygen saturation (ScvO2).

**Why the Correct Answer is Right:**

Anesthetic agents, such as volatile halogenated hydrocarbons, have higher solubility in low-pressure gases compared to high-pressure gases. This means that the anesthetic agent will dissolve more easily in the blood plasma when the arterial PCO2 (carbon dioxide partial pressure) is high. In addition, decreasing the central venous pressure will increase the concentration gradient for the anesthetic agent to pass from the blood plasma into the alveoli, thus increasing its solubility in the blood plasma.

**Why Each Wrong Option is Incorrect:**

A. Lowering arterial PCO2 (increasing arterial CO2) would decrease the concentration gradient for the anesthetic agent to dissolve into the blood plasma. This directly contradicts the correct answer.

B. Increasing arterial CO2 (lowering PCO2) would increase the partial pressure of CO2 in the arterial blood, making it more difficult for the anesthetic agent to diffuse into the blood plasma and also contradicts the correct answer.

C. Increasing central venous pressure would decrease the concentration gradient for the anesthetic agent to dissolve into the blood plasma. This directly contradicts the correct answer.

**Clinical Pearls:**

1. Adjusting arterial PCO2 and CVP can influence the potency and efficacy of volatile anesthetic agents, respectively.
2. Maintaining an optimal balance between arterial PCO2 and CVP is crucial for administering an appropriate anesthetic depth and minimizing the adverse effects of anesthesia.
3. Monitoring arterial PCO2 and CVP during anesthesia administration will help optimize the patient's response to the anesthetic agents and minimize complications.